Sean A Yamada-Hunter

6PUBLICATIONS
37CO-AUTHORS
Proteomics and intermolecular interactions (excl. medical proteomics)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Separation technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 23, 2025
IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignancies.

Pablo Domizi, Jolanda Sarno, Astraea Jager

|May 15, 2024
Engineered CD47 protects T cells for enhanced antitumour immunity.

Sean A Yamada-Hunter, Johanna Theruvath, Brianna J McIntosh

|Mar 21, 2024
Directed evolution of genetically encoded LYTACs for cell-mediated delivery.

Jonathan Lee Yang, Sean A Yamada-Hunter, Louai Labanieh

|Nov 29, 2023
An engineered interleukin-11 decoy cytokine inhibits receptor signaling and proliferation in lung adenocarcinoma.

Brianna J McIntosh, Griffin G Hartmann, Sean A Yamada-Hunter

|Apr 13, 2021
An engineered ligand trap inhibits leukemia inhibitory factor as pancreatic cancer treatment strategy.

Sean A Hunter, Brianna J McIntosh, Yu Shi

Pageof 1